Tag #Vicebio

Showing 1 to 2 of 2 results

dailymail.co.uk
🌐 85% Global Worthiness
News related image

Sanofi to Acquire Vicebio for $1.6 Billion, Expanding Vaccine Portfolio

French pharmaceutical giant Sanofi is acquiring British biotech firm Vicebio for up to $1.6 billion, gaining access to its novel combination vaccine candidate for RSV and hMPV, and its 'Molecular Clamp' technology, with the deal expected to close in the fourth quarter of 2025.

Progress

32% Bias Score

Good Health and Well-being
fr.euronews.com
🌐 85% Global Worthiness
News related image

Sanofi Acquires Vicebio for €980 Million, Expanding Respiratory Vaccine Portfolio

Sanofi is acquiring British biotech firm Vicebio for €980 million plus potential milestone payments, gaining access to a combined hMPV/RSV vaccine and Molecular Clamp technology to accelerate vaccine development and address global respiratory infections.

Progress

44% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results